B

BiomeSense

At-home biosensor with AI microbiome analytics

Technical Operations Engineer

Full-Time
$60k - $70k/yr+ Bonus + Up to 0.1% equity
Entry
Bachelor's
Chicago, IL, USA
In Person
Biology & BiotechBiomedical Engineering & Medical Devices

About the job

Requirements
  • A Bachelor of Science in Mechanical Engineering, Electrical Engineering, Mechatronics Engineering, Biomedical Engineering, or a similar discipline is required.
  • Strong understanding of electromechanical devices and their interactions is required.
  • Must enjoy hands-on work with life sciences technology.
  • Ability and desire to troubleshoot technical issues is required.
  • Must be organized, proactive, and independent, with attention to detail and communication skills.
  • Must be ready to work in a startup environment and adapt to unclaimed challenges.
Responsibilities
  • Handle day-to-day maintenance and changes on GutLab units, including mechanical, electrical, and firmware work.
  • Keep units functional and deployment-ready and improve the processes and tooling that support them.
  • Prepare and release GutLab hardware for upcoming partnership deployments and support the Operations team's day-to-day needs.
  • Log failures, investigate root causes, follow through on fixes, and keep quality metrics and tracking current.
  • Support next-generation hardware builds alongside senior engineers, from design through assembly.
  • Take on mechanical design problems and iterate toward measurable performance gains.

About the company

BiomeSense provides an integrated platform for gut microbiome analysis, combining an at-home biosensor for continuous monitoring with a cloud-based, AI-powered data analysis system. Users collect longitudinal microbiome data at home, which is securely transmitted to the cloud where AI algorithms identify patterns and track changes over time. The company differentiates itself by offering a low-cost, large-scale hardware-and-software solution designed for clinical trials and consumer health, rather than relying on single-time-point tests. Its goal is to help researchers and product teams use microbiome data to understand health and disease and advance precision medicine.

Company Size

11-50

Company Stage

Seed

Total Funding

$5.4M

Headquarters

Chicago, Illinois

Founded

2018

Get referred to BiomeSense

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BiomeSense won a $676,980 NIH SBIR/STTR award in June 2026.
  • The October 2025 $7M round added Labcorp Venture Fund and Bluestein Ventures.
  • Updated August 2026 website shows active product development and partner messaging.

What critics are saying

  • The 2024 Pendulum pilot enrolled only 15 people, proving science, not revenue.
  • BiomeSense still lacks broad commercial traction; 2026 evidence shows grants, not scaled contracts.
  • If GutLab adoption stalls, larger microbiome platforms and simple sequencing workflows outcompete BiomeSense.

What makes BiomeSense unique

  • GutLab and MetaBiome target continuous, longitudinal microbiome data, not single stool snapshots.
  • BiomeSense claims 30x more data and up to 90% per-sample cost reduction.
  • Pendulum’s 2024 pilot validated home-based serial sampling with BiomeSense's GutLab.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Stock Options
  • Paid Vacation
  • Parental Leave

Growth & Insights and Company News

Headcount

6 month growth

-5%

1 year growth

-5%

2 year growth

-5%
Crain Communications
Oct 20th, 2025
BiomeSense raises $7M for gut tests

Chicago-based startup BiomeSense has secured $7M in funding to advance technology aimed at making gut microbiome testing as common as genetic testing.

The Business Journals
May 10th, 2023
BiomeSense CEO describes 'ups and downs' of scaling a biotech startup in Chicago

'Our seed round was meant to get us to a certain milestone, but because of Covid, we weren't able to get there.' BiomeSense CEO gets candid about the Chicago biotech starutps 'seed-2' financing.